
    
      The investigators will assess tolerability and safety at scheduled intervals via standard of
      care physical exam findings, monitoring complete blood count, serum chemistry, and pulmonary
      function tests, along with patient reports of medication intolerance and change in symptoms
      of dyspnea.
    
  